Drug
Dexketoprofen Trometamol Tramadol
Dexketoprofen Trometamol Tramadol: highest development phase Post-Market, developed by Menarini. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Menarini
Trials
| Drug | Phase | Indication |
|---|---|---|
| Dexketoprofen Trometamol 25 mg/Tramadol Hydrochloride 75 mg NCT05170841 | Post-Market | Low Back Pain |
Latest
No recent events.
Follow Dexketoprofen Trometamol Tramadol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.